Portfolio (Quarterly)
Guide ↗
Decheng Capital LLC
· CIK 0002010850| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CGON | CG ONCOLOGY INC | Healthcare | 6,371,669.0 | $431.2M | 65.21% | — | — | $67.68 | -19.6% |
| 2 | NUVB | Nuvation Bio Inc. | Healthcare | 25,954,439.0 | $111.3M | 16.84% | — | — | $4.29 | +11.9% |
| 3 | — | Upstream Bio Inc. | — | 2,724,868.0 | $24.5M | 3.71% | -418K | -13.3% | $9.00 | — |
| 4 | ACRS | Aclaris Therapeutics, Inc. | Healthcare | 4,041,736.0 | $15.2M | 2.29% | — | — | $3.75 | +16.3% |
| 5 | AARD | AARDVARK THERAPEUTICS INC | Healthcare | 3,917,299.0 | $14.8M | 2.23% | — | — | $3.77 | -4.8% |
| 6 | — | Lyell Immunopharma, Inc. | — | 692,050.0 | $13.9M | 2.10% | — | — | $20.06 | — |
| 7 | — | NEWAMSTERDAM PHARMA CO NV | — | 325,057.0 | $10.4M | 1.57% | -267K | -45.1% | $32.01 | — |
| 8 | RCUS | Arcus Biosciences, Inc | Healthcare | 477,819.0 | $10.3M | 1.56% | -64K | -11.8% | $21.60 | +8.0% |
| 9 | RVMD | REVOLUTION MEDICINES INC(NSM) | Healthcare | 93,500.0 | $9.1M | 1.38% | -106K | -53.2% | $97.25 | +52.7% |
| 10 | EQ | Equillium Inc. | Healthcare | 4,447,308.0 | $8.9M | 1.34% | — | — | $2.00 | +38.5% |
| 11 | BYSI | BeyondSpring Inc. | Healthcare | 3,800,702.0 | $6.2M | 0.94% | — | — | $1.64 | +3.7% |
| 12 | ZNTL | Zentalis Pharmaceuticals Inc. | Healthcare | 1,323,327.0 | $3.1M | 0.47% | — | — | $2.34 | +53.0% |
| 13 | KRYS | KRYSTAL BIOTECH INC | Healthcare | 7,300.0 | $1.9M | 0.28% | -10K | -57.8% | $258.32 | +16.8% |
| 14 | PYXS | Pyxis Oncology, Inc (formerly Apexigen) | Healthcare | 326,810.0 | $477K | 0.07% | — | — | $1.46 | +15.8% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%